↓ Skip to main content

Oncotarget

Predictive biomarkers for sacituzumab govitecan efficacy in Trop-2-expressing triple-negative breast cancer

Overview of attention for article published in Oncotarget, October 2020
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

news
5 news outlets
blogs
1 blog
twitter
5 X users
facebook
1 Facebook page
video
1 YouTube creator

Citations

dimensions_citation
22 Dimensions

Readers on

mendeley
48 Mendeley
Title
Predictive biomarkers for sacituzumab govitecan efficacy in Trop-2-expressing triple-negative breast cancer
Published in
Oncotarget, October 2020
DOI 10.18632/oncotarget.27766
Pubmed ID
Authors

Thomas M. Cardillo, Diane L. Rossi, Maria B. Zalath, Donglin Liu, Roberto Arrojo, Robert M. Sharkey, Chien-Hsing Chang, David M. Goldenberg

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 48 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 48 100%

Demographic breakdown

Readers by professional status Count As %
Other 6 13%
Student > Master 5 10%
Researcher 5 10%
Student > Bachelor 4 8%
Lecturer 2 4%
Other 6 13%
Unknown 20 42%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 9 19%
Medicine and Dentistry 6 13%
Agricultural and Biological Sciences 4 8%
Materials Science 2 4%
Immunology and Microbiology 2 4%
Other 3 6%
Unknown 22 46%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 46. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 May 2022.
All research outputs
#799,692
of 23,577,654 outputs
Outputs from Oncotarget
#296
of 14,436 outputs
Outputs of similar age
#23,026
of 421,622 outputs
Outputs of similar age from Oncotarget
#6
of 73 outputs
Altmetric has tracked 23,577,654 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 14,436 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.8. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 421,622 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 73 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.